TSHA TAYSHA GENE THERAPIES INC
2026Q1 · CUSIP 877619106 · Sector: Healthcare & Biotech
Fading · Price holds, watch
Holders
190
Δ holders QoQ
-4
Breadth percentile
Top 76%
Whale holders
105
Δ whales
0
Inst. holding value
$1.2B
New positions
35
Closed positions
39
Price momentum (1Q)
+18.9%
Put / Call
3/4
Breadth history (34 quarters)
Past Lit Events & Aftermath 4 lit events
| Period | Percentile | Next-1Q return | Next-2Q return |
|---|---|---|---|
| 2025Q4 | Top 14% | +18.9% | — |
| 2025Q2 | Top 14% | +41.0% | +58.7% |
| 2024Q1 | Top 14% | -27.5% | -33.3% |
| 2023Q3 | Top 6% | +36.9% | +96.8% |
Options Sentiment
Put holders
3
QoQ: 0
Call holders
4
QoQ: -2
See methodology →
Fundamentals
PE (TTM)
—
EPS (TTM)
$-0.38
EPS YoY
—
Revenue (TTM)
$0.0B
Revenue YoY
+3.4%
Net margin
—
ROE
-61.3%
Debt ratio
29.4%
FCF (TTM)
-$112M
Dividend (TTM)
No dividend
Quarterly Revenue & EPS (4Y)
Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable
As of 2026-03-31 · SEC filings (XBRL)
Get the next update
2026Q2 holdings publish around Aug 15 — subscribe to receive the lists first.